• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

树枝状大分子在医学应用中的安全挑战与应用策略

Safety Challenges and Application Strategies for the Use of Dendrimers in Medicine.

作者信息

Li Xiang, Naeem Abid, Xiao Shanghua, Hu Lei, Zhang Jing, Zheng Qin

机构信息

National Pharmaceutical Engineering Center for Solid Preparation in Chinese Herbal Medicine, Jiangxi University of Chinese Medicine, Nanchang 330006, China.

Key Laboratory of Modern Preparation of TCM, Ministry of Education, Jiangxi University of Chinese Medicine, Nanchang 330004, China.

出版信息

Pharmaceutics. 2022 Jun 17;14(6):1292. doi: 10.3390/pharmaceutics14061292.

DOI:10.3390/pharmaceutics14061292
PMID:35745863
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9230513/
Abstract

Dendrimers are used for a variety of applications in medicine but, due to their host-guest and entrapment characteristics, are particularly used for the delivery of genes and drugs. However, dendrimers are intrinsically toxic, thus creating a major limitation for their use in biological systems. To reduce such toxicity, biocompatible dendrimers have been designed and synthesized, and surface engineering has been used to create advantageous changes at the periphery of dendrimers. Although dendrimers have been reviewed previously in the literature, there has yet to be a systematic and comprehensive review of the harmful effects of dendrimers. In this review, we describe the routes of dendrimer exposure and their distribution in vivo. Then, we discuss the toxicity of dendrimers at the organ, cellular, and sub-cellular levels. In this review, we also describe how technology can be used to reduce dendrimer toxicity, by changing their size and surface functionalization, how dendrimers can be combined with other materials to generate a composite formulation, and how dendrimers can be used for the diagnosis of disease. Finally, we discuss future challenges, developments, and research directions in developing biocompatible and safe dendrimers for medical purposes.

摘要

树枝状大分子在医学中有多种应用,但由于其主客体和包封特性,特别用于基因和药物递送。然而,树枝状大分子具有内在毒性,因此在生物系统中的应用存在重大限制。为降低此类毒性,已设计并合成了生物相容性树枝状大分子,并采用表面工程在树枝状大分子的外围产生有利变化。尽管此前文献中已有关于树枝状大分子的综述,但尚未有对其有害影响进行系统全面的综述。在本综述中,我们描述了树枝状大分子的暴露途径及其在体内的分布。然后,我们讨论了树枝状大分子在器官、细胞和亚细胞水平的毒性。在本综述中,我们还描述了如何通过改变其大小和表面功能化来利用技术降低树枝状大分子的毒性,树枝状大分子如何与其他材料结合以生成复合制剂,以及树枝状大分子如何用于疾病诊断。最后,我们讨论了开发用于医学目的的生物相容性和安全树枝状大分子的未来挑战、发展和研究方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ed8/9230513/c6147e7a6b9a/pharmaceutics-14-01292-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ed8/9230513/a5c1a0f1f7eb/pharmaceutics-14-01292-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ed8/9230513/4d8785fb8248/pharmaceutics-14-01292-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ed8/9230513/b2d4353e8801/pharmaceutics-14-01292-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ed8/9230513/c6147e7a6b9a/pharmaceutics-14-01292-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ed8/9230513/a5c1a0f1f7eb/pharmaceutics-14-01292-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ed8/9230513/4d8785fb8248/pharmaceutics-14-01292-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ed8/9230513/b2d4353e8801/pharmaceutics-14-01292-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ed8/9230513/c6147e7a6b9a/pharmaceutics-14-01292-g004.jpg

相似文献

1
Safety Challenges and Application Strategies for the Use of Dendrimers in Medicine.树枝状大分子在医学应用中的安全挑战与应用策略
Pharmaceutics. 2022 Jun 17;14(6):1292. doi: 10.3390/pharmaceutics14061292.
2
Dendrimer toxicity: Let's meet the challenge.树状高分子毒性:让我们迎接挑战。
Int J Pharm. 2010 Jul 15;394(1-2):122-42. doi: 10.1016/j.ijpharm.2010.04.027. Epub 2010 Apr 28.
3
Toxicity and Surface Modification of Dendrimers: A Critical Review.树突状聚合物的毒性与表面修饰: 批判性综述。
Curr Drug Deliv. 2022;19(4):451-465. doi: 10.2174/1567201818666211021160441.
4
Design of biocompatible dendrimers for cancer diagnosis and therapy: current status and future perspectives.用于癌症诊断和治疗的生物相容性树枝状聚合物的设计:现状和未来展望。
Chem Soc Rev. 2011 May;40(5):2673-703. doi: 10.1039/c0cs00097c. Epub 2011 Feb 1.
5
PEGylated PAMAM dendrimers: Enhancing efficacy and mitigating toxicity for effective anticancer drug and gene delivery.聚乙二醇化聚酰胺-胺树枝状大分子:增强疗效并减轻毒性以实现有效的抗癌药物和基因递送
Acta Biomater. 2016 Oct 1;43:14-29. doi: 10.1016/j.actbio.2016.07.015. Epub 2016 Jul 12.
6
Pharmaceutical and biomedical potential of surface engineered dendrimers.表面工程树枝状大分子的药学与生物医学潜力
Crit Rev Ther Drug Carrier Syst. 2007;24(3):257-306. doi: 10.1615/critrevtherdrugcarriersyst.v24.i3.20.
7
Dendrimers: a class of polymers in the nanotechnology for the delivery of active pharmaceuticals.树枝状聚合物:纳米技术中用于递送活性药物的一类聚合物。
Curr Pharm Des. 2009;15(25):2958-69. doi: 10.2174/138161209789058200.
8
Surface functionalized dendrimers as controlled-release delivery nanosystems for tumor targeting.表面功能化树枝状聚合物作为肿瘤靶向的控释递药纳米系统。
Eur J Pharm Sci. 2018 Sep 15;122:311-330. doi: 10.1016/j.ejps.2018.07.020. Epub 2018 Jul 9.
9
Dendrimer biocompatibility and toxicity.树枝状大分子的生物相容性和毒性。
Adv Drug Deliv Rev. 2005 Dec 14;57(15):2215-37. doi: 10.1016/j.addr.2005.09.019. Epub 2005 Nov 16.
10
Self-Assembling Supramolecular Dendrimers for Biomedical Applications: Lessons Learned from Poly(amidoamine) Dendrimers.自组装超分子树状聚合物在生物医学中的应用:聚(酰胺-胺)树状聚合物的经验教训。
Acc Chem Res. 2020 Dec 15;53(12):2936-2949. doi: 10.1021/acs.accounts.0c00589. Epub 2020 Dec 4.

引用本文的文献

1
Harnessing the Power of Nanocarriers to Exploit the Tumor Microenvironment for Enhanced Cancer Therapy.利用纳米载体的力量开发肿瘤微环境以增强癌症治疗效果
Pharmaceuticals (Basel). 2025 May 19;18(5):746. doi: 10.3390/ph18050746.
2
Advances in nanomaterials for precision drug delivery: Insights into pharmacokinetics and toxicity.用于精准给药的纳米材料研究进展:药代动力学与毒性洞察
Bioimpacts. 2024 Nov 2;15:30573. doi: 10.34172/bi.30573. eCollection 2025.
3
Revolutionizing mRNA Vaccines Through Innovative Formulation and Delivery Strategies.

本文引用的文献

1
Advanced nanocarrier- and microneedle-based transdermal drug delivery strategies for skin diseases treatment.先进的基于纳米载体和微针的经皮给药策略治疗皮肤病。
Theranostics. 2022 Apr 11;12(7):3372-3406. doi: 10.7150/thno.69999. eCollection 2022.
2
An Overview of Nanotechnologies for Drug Delivery to the Brain.用于脑部药物递送的纳米技术概述。
Pharmaceutics. 2022 Jan 19;14(2):224. doi: 10.3390/pharmaceutics14020224.
3
The effect of maltose modified fourth generation poly(propylene imine) (PPI G4) dendrimers on the barrier functions and inflammatory activation of human vascular endothelium - Possible consequences for the medical application.
通过创新的制剂和递送策略革新mRNA疫苗。
Biomolecules. 2025 Mar 1;15(3):359. doi: 10.3390/biom15030359.
4
Human Embryonic Kidney HEK293 Cells as a Model to Study SMVT-Independent Transport of Biotin and Biotin-Furnished Nanoparticles in Targeted Therapy.人胚肾HEK293细胞作为研究生物素及生物素修饰纳米颗粒在靶向治疗中不依赖SMVT转运的模型
Int J Mol Sci. 2025 Feb 13;26(4):1594. doi: 10.3390/ijms26041594.
5
Precision Therapy for Prostate Cancer: Advancements in Polymeric Nanocarrier Systems.前列腺癌的精准治疗:聚合物纳米载体系统的进展
Anticancer Agents Med Chem. 2025 Jan 30. doi: 10.2174/0118715206360906241223120425.
6
Non-Viral Delivery Systems to Transport Nucleic Acids for Inherited Retinal Disorders.用于遗传性视网膜疾病的核酸运输非病毒递送系统。
Pharmaceuticals (Basel). 2025 Jan 13;18(1):87. doi: 10.3390/ph18010087.
7
Navigating liver cancer: Precision targeting for enhanced treatment outcomes.应对肝癌:精准靶向治疗以提高治疗效果。
Drug Deliv Transl Res. 2025 Jun;15(6):1935-1961. doi: 10.1007/s13346-024-01780-x. Epub 2025 Jan 23.
8
Comparative Study of Functionalized Carbosilane Dendrimers for siRNA Delivery: Synthesis, Cytotoxicity, and Biophysical Properties.用于 siRNA 递送的功能化碳硅烷树枝状大分子的比较研究:合成、细胞毒性和生物物理性质
ACS Omega. 2024 Dec 20;10(1):1047-1060. doi: 10.1021/acsomega.4c08314. eCollection 2025 Jan 14.
9
Nanotechnology-Based Approaches for the Management of Diabetes Mellitus: An Innovative Solution to Long-Lasting Challenges in Antidiabetic Drug Delivery.基于纳米技术的糖尿病管理方法:抗糖尿病药物递送长期挑战的创新解决方案
Pharmaceutics. 2024 Dec 9;16(12):1572. doi: 10.3390/pharmaceutics16121572.
10
How Dendrimers Impact Fibrin Clot Formation, Structure, and Properties.树枝状大分子如何影响纤维蛋白凝块的形成、结构和性质。
ACS Omega. 2024 Dec 18;9(52):51306-51319. doi: 10.1021/acsomega.4c08120. eCollection 2024 Dec 31.
麦芽糖修饰的第四代聚(丙烯亚胺)(PPI G4)树枝状大分子对人血管内皮屏障功能和炎症激活的影响——对医学应用的潜在影响
Vascul Pharmacol. 2022 Apr;143:106972. doi: 10.1016/j.vph.2022.106972. Epub 2022 Feb 14.
4
Synthesis of Biotinylated PAMAM G3 Dendrimers Substituted with -Glycidol and Celecoxib/Simvastatin as Repurposed Drugs and Evaluation of Their Increased Additive Cytotoxicity for Cancer Cell Lines.用缩水甘油和塞来昔布/辛伐他汀取代的生物素化聚酰胺-胺型第3代树枝状大分子的合成作为重新利用的药物及其对癌细胞系增加的相加细胞毒性评估
Cancers (Basel). 2022 Jan 29;14(3):714. doi: 10.3390/cancers14030714.
5
Ocular Nanomedicine.眼纳米医学。
Adv Sci (Weinh). 2022 May;9(15):e2003699. doi: 10.1002/advs.202003699. Epub 2022 Feb 12.
6
Biotin Transport-Targeting Polysaccharide-Modified PAMAM G3 Dendrimer as System Delivering α-Mangostin into Cancer Cells and Worms.生物素转运靶向多糖修饰的 PAMAM G3 树枝状大分子作为将 α-倒捻子素递送入癌细胞和线虫的系统。
Int J Mol Sci. 2021 Nov 29;22(23):12925. doi: 10.3390/ijms222312925.
7
Application of dendrimer-based nanosensors in immunodiagnosis.基于树状高分子的纳米传感器在免疫诊断中的应用。
Colloids Surf B Biointerfaces. 2022 Jan;209(Pt 2):112174. doi: 10.1016/j.colsurfb.2021.112174. Epub 2021 Oct 24.
8
Toxicity and Surface Modification of Dendrimers: A Critical Review.树突状聚合物的毒性与表面修饰: 批判性综述。
Curr Drug Deliv. 2022;19(4):451-465. doi: 10.2174/1567201818666211021160441.
9
The role of the electrokinetic charge of neurotrophis-based nanocarriers: protein distribution, toxicity, and oxidative stress in in vitro setting.基于神经营养因子的纳米载体的电动电荷作用:体外环境中的蛋白质分布、毒性和氧化应激。
J Nanobiotechnology. 2021 Aug 28;19(1):258. doi: 10.1186/s12951-021-00984-4.
10
Unconventional Approaches to Prepare Triazine-Based Liquid Crystal Dendrimers.制备基于三嗪的液晶树枝状大分子的非常规方法。
Nanomaterials (Basel). 2021 Aug 19;11(8):2112. doi: 10.3390/nano11082112.